InvestorsHub Logo
Followers 37
Posts 7211
Boards Moderated 1
Alias Born 09/06/2014

Re: Hawk05 post# 317223

Thursday, 06/29/2023 8:53:20 AM

Thursday, June 29, 2023 8:53:20 AM

Post# of 333440
The point is: IF Ilfeld conducts a full-scale clinical trial of the ActiPatch after his Pilot Studies, he won't finish before BIEL's patents expire.

So all the hype about Ilfeld is unfounded.

Still LYAO?

I 'm not laughing. I'm shaking my head though.